| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | SVP, Chief Legal Officer | Common Stock | 651K | $821K | $1.26 | May 13, 2024 | Direct |
| Akebia Therapeutics, Inc. | SVP, Chief Legal Officer | Stock Option (Right to buy) | 224K | Jan 31, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | May 13, 2024 | 1 | -$15.1K | 4 | May 14, 2024 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | Feb 29, 2024 | 1 | -$9.44K | 4 | Mar 1, 2024 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | Feb 27, 2024 | 1 | -$11.3K | 4 | Feb 29, 2024 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | Jan 31, 2024 | 2 | $0 | 4 | Feb 2, 2024 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | May 24, 2023 | 3 | -$77.3K | 4 | May 25, 2023 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | May 12, 2023 | 1 | $0 | 4 | May 16, 2023 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | Mar 1, 2023 | 3 | -$11.4K | 4 | Mar 3, 2023 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | Feb 27, 2023 | 1 | -$5.43K | 4 | Mar 1, 2023 | SVP, Chief Legal Officer |
| AKBA | Akebia Therapeutics, Inc. | Feb 28, 2022 | 6 | -$45.6K | 4 | Mar 2, 2022 | SVP, Chief Legal Officer |